Steven Cohen’s Damora Therapeutics DMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-48,754
Closed -$1.27M – 4174
2026
Q2
$1.27M Sell
48,754
-1,144,954
-96% -$27.7M ﹤0.01% 2680
2026
Q1
$30.9M Buy
1,193,708
+1,084,708
+995% +$27.9M 0.04% 593
2025
Q4
$2.51M Buy
+109,000
New +$1.89M ﹤0.01% 2336

Other funds holding DMRA

Steven Cohen's DMRA Position: Q3 2026 in Review

Steven Cohen sold out of Damora Therapeutics (DMRA) in Q3 2026, closing a stake of 48,754 shares — an estimated $1.27M sold.

Steven Cohen first reported a position in DMRA in Q4 2025 and held it in 3 quarters. The position peaked at $30.9M in Q1 2026. 115 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.

  • Steven Cohen reported no remaining Damora Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 48,754 Damora Therapeutics shares in Q3 2026, an estimated $1.27M.
  • Steven Cohen first reported a position in Damora Therapeutics in Q4 2025 and held it in 3 quarters.
  • Steven Cohen's Damora Therapeutics position peaked at $30.9M in Q1 2026.
  • 115 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.